Treatment decisions for localized prostate cancer: Asking men what's important

Journal of General Internal Medicine

Volumn 15, Issue 10, 2000, Pages 694-701

  Holmboe, Eric S ^a   Concato, John ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Decision making; Localized prostate cancer; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER LOCALIZATION; DECISION MAKING; HEALTH CARE PLANNING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT SATISFACTION; PROSTATE CANCER; PROSTATECTOMY;

AGED; DECISION MAKING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PROSTATIC NEOPLASMS; QUESTIONNAIRES;

EID: 0033763543     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1497.2000.90842.x     Document Type: Article

References (27)

1. Cancer statistics, 1998
2. Screening for prostate cancer with prostate-specific antigen
3. An evaluation of prostate-specific antigen as a screening test for prostate cancer
4. Concern grows over prostate cancer treatment options
5. Should we treat localized prostate cancer. An opinion
6. The natural history of localized prostate cancer: A guide to therapy
7. Screening for asymptomatic prostate cancer: Truth in advertising
8. Quality-of-life outcomes in men treated for localized prostate cancer
9. Early complications of contemporary anatomical radical retropubic prostatectomy
10. Patient-reported complications and follow-up treatment after radical prostatectomy. The national Medicare experience: 1988-1990
11. Prostate cancer: Emerging concepts. Part I
12. A decision analysis of alternative treatment strategies for clinically localized prostate cancer
13. Screening, early detection, and treatment of prostate cancer: A European view
14. Radical prostatectomy versus expectant primary treatment in stages I and II prostatic cancer. A fifteen year follow-up
15. Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association
16. For prostate cancer there's no magic bullet
17. Information seeking and satisfaction with treatment decision in patients with clinically localized prostate cancer
18. Prostate cancer screening and beliefs about treatment efficacy: A national survey of primary care physicians and urologists
19. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
20. Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: The jury is still out
21. Perception of risk
22. A decision analysis for treatment of clinically localized prostate cancer
23. Watchful waiting for early stage prostate cancer
24. Localised carcinoma of the prostate: A paradigm of uncertainty
25. The role of watchful waiting in the management of localized prostate cancer
26. An analysis of watchful waiting for clinically localized prostate cancer